Somatic copy number alterations at diagnosis and relapse in 20 childhood B-precursor ALL cases
ID . | Gains . | Losses . | Copy number alterations . | Race . | Age at diagnosis, y . | Sex . | Time to relapse, mo . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diagnosis . | Relapse . | Shared . | Diagnosis . | Relapse . | Shared . | Diagnosis . | Relapse . | Shared* . | |||||
1 | 3 | 4 | 3 | 0 | 3 | 0 | 3 | 7 | 3 | White | 6.9 | Male | 39.0 |
2† | 10 | 10 | 10 | 2 | 2 | 2 | 12 | 12 | 12 | Hispanic | 8 | Male | 20.1 |
3 | 2 | 2 | 2 | 3 | 4 | 3 | 5 | 6 | 5 | White | 7.3 | Female | 21.8 |
4† | 14 | 14 | 14 | 70 | 70 | 70 | 84 | 84 | 84 | Hispanic | 5.6 | Male | 52.2 |
5 | 2 | 4 | 2 | 15 | 18 | 14 | 17 | 22 | 16 | Hispanic | 18.3 | Male | 41.0 |
6† | 5 | 5 | 5 | 1 | 4 | 1 | 6 | 9 | 6 | White | 3.4 | Female | 21.2 |
7 | 1 | 3 | 1 | 8 | 8 | 8 | 9 | 11 | 9 | White | 9.8 | Male | 12.6 |
8 | 0 | 1 | 0 | 11 | 13 | 11 | 11 | 14 | 11 | Hispanic | 12.2 | Female | 34.9 |
9 | 0 | 1 | 0 | 19 | 21 | 19 | 19 | 22 | 19 | White | 7.7 | Male | 10.6 |
10 | 0 | 0 | 0 | 6 | 7 | 5 | 6 | 7 | 5 | White | 1.9 | Female | 37.8 |
11 | 0 | 0 | 0 | 9 | 8 | 7 | 9 | 8 | 7 | White | 12 | Female | 49.6 |
12 | 3 | 3 | 3 | 9 | 10 | 9 | 12 | 13 | 12 | White | 7.6 | Female | 21.7 |
13 | 1 | 1 | 1 | 9 | 11 | 8 | 10 | 12 | 9 | White | 14.3 | Male | 19.1 |
14 | 4 | 4 | 4 | 9 | 7 | 7 | 13 | 11 | 11 | White | 8.4 | Female | 30.3 |
15 | 1 | 2 | 1 | 38 | 31 | 14 | 39 | 33 | 15 | White | 12.6 | Male | 17.2 |
16 | 13 | 19 | 13 | 25 | 29 | 25 | 38 | 48 | 38 | White | 5.7 | Male | 14.7 |
17 | 4 | 4 | 4 | 10 | 9 | 9 | 14 | 13 | 13 | White | 2.4 | Male | 13.3 |
18 | 2 | 2 | 2 | 3 | 3 | 3 | 5 | 5 | 5 | Black | 9.3 | Female | 7.6 |
19‡ | 4 | 12 | 2 | 21 | 22 | 21 | 25 | 34 | 23 | White | 5.9 | Male | 10.6 |
20 | 5 | 4 | 4 | 20 | 21 | 20 | 25 | 25 | 24 | White | 11.9 | Male | 10.3 |
Total | 74 | 95 | 71 | 288 | 301 | 256 | 362 | 396 | 327 |
ID . | Gains . | Losses . | Copy number alterations . | Race . | Age at diagnosis, y . | Sex . | Time to relapse, mo . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diagnosis . | Relapse . | Shared . | Diagnosis . | Relapse . | Shared . | Diagnosis . | Relapse . | Shared* . | |||||
1 | 3 | 4 | 3 | 0 | 3 | 0 | 3 | 7 | 3 | White | 6.9 | Male | 39.0 |
2† | 10 | 10 | 10 | 2 | 2 | 2 | 12 | 12 | 12 | Hispanic | 8 | Male | 20.1 |
3 | 2 | 2 | 2 | 3 | 4 | 3 | 5 | 6 | 5 | White | 7.3 | Female | 21.8 |
4† | 14 | 14 | 14 | 70 | 70 | 70 | 84 | 84 | 84 | Hispanic | 5.6 | Male | 52.2 |
5 | 2 | 4 | 2 | 15 | 18 | 14 | 17 | 22 | 16 | Hispanic | 18.3 | Male | 41.0 |
6† | 5 | 5 | 5 | 1 | 4 | 1 | 6 | 9 | 6 | White | 3.4 | Female | 21.2 |
7 | 1 | 3 | 1 | 8 | 8 | 8 | 9 | 11 | 9 | White | 9.8 | Male | 12.6 |
8 | 0 | 1 | 0 | 11 | 13 | 11 | 11 | 14 | 11 | Hispanic | 12.2 | Female | 34.9 |
9 | 0 | 1 | 0 | 19 | 21 | 19 | 19 | 22 | 19 | White | 7.7 | Male | 10.6 |
10 | 0 | 0 | 0 | 6 | 7 | 5 | 6 | 7 | 5 | White | 1.9 | Female | 37.8 |
11 | 0 | 0 | 0 | 9 | 8 | 7 | 9 | 8 | 7 | White | 12 | Female | 49.6 |
12 | 3 | 3 | 3 | 9 | 10 | 9 | 12 | 13 | 12 | White | 7.6 | Female | 21.7 |
13 | 1 | 1 | 1 | 9 | 11 | 8 | 10 | 12 | 9 | White | 14.3 | Male | 19.1 |
14 | 4 | 4 | 4 | 9 | 7 | 7 | 13 | 11 | 11 | White | 8.4 | Female | 30.3 |
15 | 1 | 2 | 1 | 38 | 31 | 14 | 39 | 33 | 15 | White | 12.6 | Male | 17.2 |
16 | 13 | 19 | 13 | 25 | 29 | 25 | 38 | 48 | 38 | White | 5.7 | Male | 14.7 |
17 | 4 | 4 | 4 | 10 | 9 | 9 | 14 | 13 | 13 | White | 2.4 | Male | 13.3 |
18 | 2 | 2 | 2 | 3 | 3 | 3 | 5 | 5 | 5 | Black | 9.3 | Female | 7.6 |
19‡ | 4 | 12 | 2 | 21 | 22 | 21 | 25 | 34 | 23 | White | 5.9 | Male | 10.6 |
20 | 5 | 4 | 4 | 20 | 21 | 20 | 25 | 25 | 24 | White | 11.9 | Male | 10.3 |
Total | 74 | 95 | 71 | 288 | 301 | 256 | 362 | 396 | 327 |